Improving the Rate of Translation of Tissue Engineering Products
- PMID: 31386306
- DOI: 10.1002/adhm.201900538
Improving the Rate of Translation of Tissue Engineering Products
Abstract
Over 100 000 research articles and 9000 patents have been published on tissue engineering (TE) in the past 20 years. Yet, very few TE products have made their way to the market during the same period. Experts have proposed a variety of strategies to address the lack of translation of TE products. However, since these proposals are guided by qualitative insights, they are limited in scope and impact. Machine learning is utilized in the current study to analyze the entire body of patents that have been published over the past twenty years and understand patenting trends, topics, areas of application, and exemplifications. This analysis yields surprising and little-known insights about the differences in research priorities and perceptions of innovativeness of tissue engineers in academia and industry, as well as aids to chart true advances in the field during the past twenty years. It is hoped that this analysis and subsequent proposal to improve translational rates of TE products will spur much needed dialogue about this important pursuit.
Keywords: biopharmaceutical industry; innovation; machine learning; tissue engineering; translation.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Emerging Translation of Regenerative Therapies.Clin Pharmacol Ther. 2017 Jan;101(1):28-30. doi: 10.1002/cpt.549. Epub 2016 Nov 26. Clin Pharmacol Ther. 2017. PMID: 27806427
-
Tissue engineering and regenerative medicine: recent innovations and the transition to translation.Tissue Eng Part B Rev. 2013 Feb;19(1):1-13. doi: 10.1089/ten.TEB.2012.0723. Tissue Eng Part B Rev. 2013. PMID: 23253031 Free PMC article. Review.
-
Regenerative medicine primer.Mayo Clin Proc. 2013 Jul;88(7):766-75. doi: 10.1016/j.mayocp.2013.04.017. Mayo Clin Proc. 2013. PMID: 23809322 Review.
-
Tissue engineering and regenerative medicine -where do we stand?J Cell Mol Med. 2012 Jun;16(6):1157-65. doi: 10.1111/j.1582-4934.2012.01564.x. J Cell Mol Med. 2012. PMID: 22436120 Free PMC article. Review.
-
Recent advances in regenerative medicine strategies for cancer treatment.Biomed Pharmacother. 2021 Sep;141:111875. doi: 10.1016/j.biopha.2021.111875. Epub 2021 Jul 3. Biomed Pharmacother. 2021. PMID: 34229250 Review.
Cited by
-
Recent advances in artificial intelligent strategies for tissue engineering and regenerative medicine.Skin Res Technol. 2024 Sep;30(9):e70016. doi: 10.1111/srt.70016. Skin Res Technol. 2024. PMID: 39189880 Free PMC article. Review.
-
Highlights on Advancing Frontiers in Tissue Engineering.Tissue Eng Part B Rev. 2022 Jun;28(3):633-664. doi: 10.1089/ten.TEB.2021.0012. Epub 2021 Oct 25. Tissue Eng Part B Rev. 2022. PMID: 34210148 Free PMC article. Review.
-
Biocompatibility Study of Hydrogel Biopolymer Scaffold with Encapsulated Mesenchymal Stem Cells.Polymers (Basel). 2023 Mar 7;15(6):1337. doi: 10.3390/polym15061337. Polymers (Basel). 2023. PMID: 36987118 Free PMC article.
-
Engineering skeletal muscle: Building complexity to achieve functionality.Semin Cell Dev Biol. 2021 Nov;119:61-69. doi: 10.1016/j.semcdb.2021.04.016. Epub 2021 May 11. Semin Cell Dev Biol. 2021. PMID: 33994095 Free PMC article. Review.
-
The cell-assembled extracellular matrix: A focus on the storage stability and terminal sterilization of this human "bio" material.Acta Biomater. 2023 Aug;166:133-146. doi: 10.1016/j.actbio.2023.05.002. Epub 2023 May 5. Acta Biomater. 2023. PMID: 37149079 Free PMC article.
References
-
- R. Langer, J. Vacanti, Science 1993, 260, 920.
-
- A. Khademhosseini, J. P. Vacanti, R. Langer, Sci. Am. 2009, 300, 64.
-
- A. Khademhosseini, R. Langer, Nat. Protoc. 2016, 11, 1775.
-
- J. Vacanti, R. Langer, Sci. Am. 1999, 280, 86.
-
- Thumbs Up for Organs ‘Grown to Order', https://bbc.in/2UxSDkE (accessed: November 2018).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous